ADAPTIMMUNE

Live / Registered — Registered (as of 25 Jan 2022)

What this means for you

Registered since 25 Jan 2022. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
79312975
Registration number
6624493
Mark type
Design + words
Filed
31 Mar 2021
Published for opposition
09 Nov 2021
Registered
25 Jan 2022
Attorney of record
Christiane Campbell

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer and autoimmune diseases; pharmaceutical immunotherapy preparations for use in cancer treatment; T-cell receptors , namely, pharmaceutical preparations for use in cancer treatment; pharmaceutical immunotherapy preparations comprising engineered T-cell receptors for use in cancer treatment; pharmaceutical immunotherapy preparations comprising genes encoding engineered T-cell receptors for use in cancer treatment
  • Class 044 — Medical, beauty and agricultural services: Medical treatment services; medical immunotherapy services; medical treatment services and medical treatment services for immune-therapy comprising harvesting a patient's white blood cells, combining white blood cells with an engineered T-cell receptor therapeutic, transducing the white blood cells with the gene encoding the engineered T-cell receptor and infusion of the transduced white blood cells back into the patient

Owner

Prosecution history

  • 01 Aug 2022 — FINAL DECISION TRANSACTION PROCESSED BY IB
  • 08 Jul 2022 — FINAL DISPOSITION NOTICE SENT TO IB
  • 08 Jul 2022 — FINAL DISPOSITION PROCESSED
  • 25 Apr 2022 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
  • 25 Jan 2022 — REGISTERED-PRINCIPAL REGISTER
  • 09 Nov 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 09 Nov 2021 — PUBLISHED FOR OPPOSITION
  • 20 Oct 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 07 Oct 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 13 Sept 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 13 Sept 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 13 Sept 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 15 Aug 2021 — REFUSAL PROCESSED BY IB
  • 27 Jul 2021 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
  • 27 Jul 2021 — REFUSAL PROCESSED BY MPU

View this trademark record on Marksy